Fuan Pharmaceutical: Subsidiary receives drug registration certificate

2026-04-08 16:45:32

People’s Finance News, April 7: On April 7, Fuan Pharmaceutical (300194) issued an announcement stating that its wholly owned subsidiary, Fuan Pharmaceutical Group Qing Yutang Pharmaceutical Co., Ltd., has recently received a drug registration certificate for Sulinic Acid Tablets issued by the National Medical Products Administration. Sulinic Acid Tablets are indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis, joint-related conditions such as acute pain (acute subacromial bursitis/acromial tendonitis), and tenosynovitis; acute gouty arthritis; pain low back syndrome (low back pain, typically attributed to low back pain); and signs and symptoms of upper respiratory tract infections.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes